37
61
Growth Score
-18 pts
Heat Score
-23 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
234738
Gemini Bio-Products is an FDA-registered provider of biological products and chemical reagents to the global cell culture community.
Acquired by 
BelHealth Investment Partners
- Brian Parker: Chief Executive OfficerPast Role: Thermo Fisher Scientific, Vice President/ General Manager, Asymptomatic Testing Solutions
- Ed Mendham: Chief Financial OfficerPast Role: BelHealth Investment Partners, VP of Finance
About the Company
Gemini Bio-Products manufactures biological products and chemical reagents for the cell culture community globally. It offers cell culture sera, such as fetal bovine, specialized fetal bovine, other non-fetal, human and animal sera; custom and specialized media; and supplements and reagents, including amino acids, antibiotics and antimycotics,
culture supplements and albumins, recombinant proteins, attachment factors, and cell dissociation reagents.
